Inventor · disambiguated record
Denisa D. Wagner
Also filed as: WAGNER DENISA · WAGNER DENISA D
13 granted patents·15 pending applications·62 citations·filing 1995–2025
89Inventor score
Files withCHILDRENS MEDICAL CENTER7CHILDRENS MEDICAL CT CORP4BLOOD RES CENTER3TAKEDA PHARMACEUTICALS CO2BRIGHAM & WOMENS HOSPITAL INC1
Top patents by PatentIndex Score
28 records- 0190US9642822B2Methods for treating and preventing neutrophil-derived net toxicity and thrombosisWAGNER DENISA D·Filed 2012·Granted May 9, 2017·26 cites·17 claims
- 0280US7387777B2Methods of treating hemophilia or von willebrand disease with p-selectinBLOOD RES CENTER·Filed 2004·Granted Jun 17, 2008·17 cites·7 claims
- 0380US2024238388A1Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2023·Application pending·0 cites
- 0476US2025262284A1Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2025·Application pending·0 cites
- 0571US11124787B2ADAMTS13-containing compositions having thrombolytic activityTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 21, 2021·0 cites·17 claims
- 0671US7271152B2Compounds and methods for the modulation of CD154CBR INST FOR BIOMEDICAL RES·Filed 2002·Granted Sep 18, 2007·11 cites·44 claims
- 0771US2022002703A1Adamts13-containing compositions having thrombolytic activityTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 0870US11819540B2Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2020·Granted Nov 21, 2023·0 cites·30 claims
- 0969US11510970B2Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2020·Granted Nov 29, 2022·0 cites·21 claims
- 1065US10617742B2Methods for treating and preventing neutrophil-derived net toxicity and thrombosisCHILDRENS MEDICAL CENTER·Filed 2017·Granted Apr 14, 2020·0 cites·7 claims
- 1164US6861504B2Compounds and methods for the modulation of CD154CBR INC·Filed 2001·Granted Mar 1, 2005·3 cites·7 claims
- 1264US2023190886A1Anti-net compounds for treating and preventing fibrosis and for facilitating wound healingCHILDRENS MEDICAL CT CORP·Filed 2022·Application pending·0 cites
- 1364US2025242000A1Anti-net compounds for treating and preventing fibrosis and for facilitating wound healingCHILDRENS MEDICAL CT CORP·Filed 2025·Application pending·0 cites
- 1459US10233436B2ADAMTS13-containing compositions having thrombolytic activityBaxalta GmbH·Filed 2013·Granted Mar 19, 2019·0 cites·14 claims
- 1558US2005202007A1Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activityFiled 2004·Application pending·0 cites
- 1657US2008193949A1Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activityBLOOD RES CENTER·Filed 2008·Application pending·0 cites
- 1756US2007015703A1ADAMTS13-containing compositions having thrombolytic activityWAGNER DENISA·Filed 2006·Application pending·0 cites
- 1854US11400139B2Anti-NET compounds for treating and preventing fibrosis and for facilitating wound healingCHILDRENS MEDICAL CT CORP·Filed 2016·Granted Aug 2, 2022·0 cites·15 claims
- 1954US2005019743A1Compounds and methods for improving platelet recovery and functionBLOOD RES CENTER·Filed 2004·Application pending·0 cites
- 2051US2009317375A1Von willebrand factor (vwf) inhibitors for treatment or prevention of infarctionIMMUNE DISEASE INST INC·Filed 2009·Application pending·0 cites
- 2149US2022339266A1Adamts13 treatment to enhance graft survivalCHILDRENS MEDICAL CT CORP·Filed 2020·Application pending·0 cites
- 2247US2002132225A1Compositions and methods for prolonging survival of chilled plateletsFiled 2001·Application pending·0 cites
- 2346US2002040008A1Method for treating and preventing atherosclerosisFiled 2001·Application pending·0 cites
- 2445US11426405B2Inhibition of JAK-STAT signaling inhibits formation of neutrophil extracellular traps (NETs)BRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Granted Aug 30, 2022·0 cites·10 claims
- 2542US5807745AMethod of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core componentNEW ENGLAND MEDICAL CENTER INC·Filed 1995·Granted Sep 15, 1998·5 cites·17 claims
- 2642US2018147265A1Methods relating to the treatment of colitis and inflammatory bowel diseaseCHILDRENS MEDICAL CENTER·Filed 2016·Application pending·0 cites
- 2740US10639307B2Methods relating to the diagnosis and treatment of preeclampsia comprising administration of ADAMTS13 polypeptidesCHILDRENS MEDICAL CENTER·Filed 2016·Granted May 5, 2020·0 cites·5 claims
- 2839US2002031508A1Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activityFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Denisa D. Wagner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →